SoP LibraryHypothyroidism

Statement of Principles

Hypothyroidism — DVA SoP factors

Every factor in the Repatriation Medical Authority Statements of Principles for Hypothyroidism. DVA can only accept a claim for Hypothyroidism if at least one of these factors is met and connected to your service. Reasonable Hypothesis (RH) applies to operational service; Balance of Probabilities (BoP) applies to peacetime service.

Source: Repatriation Medical Authority Statements of Principles as held by the Veterans Health Centre. SoPs are amended and replaced regularly; always confirm the current instrument at rma.gov.au before relying on it.

Hypothyroidism

RH No. 3 of 2022 · BoP No. 4 of 202280 factors

Meaning of hypothyroidism: For the purposes of this Statement of Principles, hypothyroidism: (a) means a functional disorder in which there is deficiency of thyroid hormone that produces clinical symptoms and signs or warrants medical treatment; and (b) includes: (i) primary hypothyroidism due to dysfunction of the thyroid gland; and (ii) central hypothyroidism due to decreased secretion of thyroid hormone from a functionally normal thyroid gland as a result of hypothalamic or pituitary disease; and (iii) peripheral hypothyroidism due to inactivation of thyroid hormone; and (c) excludes: (i) congenital hypothyroidism; (ii) congenital iodine-deficiency syndrome; (iii) Hashimoto thyroiditis; (iv) sick euthyroid syndrome; (v) subclinical hypothyroidism; and (vi) transient hypothyroidism during recovery from non- thyroidal illness.

Reasonable Hypothesis (RH) — Statement of Principles No. 3 of 2022

At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting hypothyroidism or death from hypothyroidism with the circumstances of a person's relevant service:

  1. (1)
    having iodine deficiency within the 6 months before the clinical onset of hypothyroidism;

    Note: iodine deficiency is defined in the Schedule 1 - Dictionary.

  2. (2)
    having iodine excess within the 6 months before the clinical onset of hypothyroidism;

    Note: Iodine excess may be due to consuming foods, dietary supplements or medications with a high content of iodine.

    Note: iodine excess is defined in the Schedule 1 - Dictionary.

  3. (3)
    being administered an iodine-containing radiographic contrast agent within the 6 months before the clinical onset of hypothyroidism;
  4. (4)
    taking a drug from the specified list of drugs within the 6 months before the clinical onset of hypothyroidism;

    Note: specified list of drugs is defined in the Schedule 1 - Dictionary.

  5. (5)
    taking minocycline for at least 6 months within the 9 months before the clinical onset of hypothyroidism;
  6. (6)
    taking a drug containing at least 10 milligrams of iodine daily for a continuous period of at least 4 weeks within the 6 months before the clinical onset of hypothyroidism;
  7. (7)
    taking amiodarone for a continuous period of at least 2 weeks within the 1 year before the clinical onset of hypothyroidism;
  8. (8)
    being pregnant or within the 12 months postpartum at the time of the clinical onset of hypothyroidism;
  9. (9)
    having a form of thyroiditis from the specified list of forms of thyroiditis at the time of the clinical onset of hypothyroidism;

    Note: specified list of forms of thyroiditis is defined in the Schedule 1 - Dictionary.

  10. (10)
    undergoing a course of therapeutic radiation for cancer, where the thyroid gland was in the field of radiation, before the clinical onset of hypothyroidism;
  11. (11)
    having received iodine-131 (radioactive iodine) treatment before the clinical onset of hypothyroidism;
  12. (12)
    having subtotal or total thyroidectomy, or neck surgery involving the thyroid gland, before the clinical onset of hypothyroidism;
  13. (13)
    having a disease involving the thyroid gland from the specified list of diseases at the time of the clinical onset of hypothyroidism;

    Note: specified list of diseases is defined in the Schedule 1 - Dictionary.

  14. (14)
    having a primary or secondary malignant neoplasm of the thyroid gland at the time of the clinical onset of hypothyroidism;
  15. (15)
    having a type 3 deiodinase-overexpressing neoplasm before the clinical onset of hypothyroidism;
  16. (16)
    having hypopituitarism involving deficiency of thyroid-stimulating hormone at the time of the clinical onset of hypothyroidism;
  17. (17)
    having chronic kidney disease at the time of the clinical onset of hypothyroidism;

    Note: chronic kidney disease is defined in the Schedule 1 - Dictionary.

  18. (18)
    having hepatitis C virus infection at the time of the clinical onset of hypothyroidism;
  19. (19)
    being obese for at least 5 years before the clinical onset of hypothyroidism;

    Note: being obese is defined in the Schedule 1 - Dictionary.

  20. (20)
    having posttraumatic stress disorder at the time of the clinical onset of hypothyroidism;
  21. (21)
    for hypothyroidism first presenting as myxoedema coma only, having an acute precipitating event within the 48 hours before the clinical onset of hypothyroidism;

    Note: acute precipitating event and myxoedema coma are defined in the Schedule 1 - Dictionary.

  22. (22)
    having iodine deficiency within the 6 months before the clinical worsening of hypothyroidism;

    Note: iodine deficiency is defined in the Schedule 1 - Dictionary.

  23. (23)
    having iodine excess within the 6 months before the clinical worsening of hypothyroidism;

    Note: Iodine excess may be due to consuming foods, dietary supplements or medications with a high content of iodine.

    Note: iodine excess is defined in the Schedule 1 - Dictionary.

  24. (24)
    being administered an iodine-containing radiographic contrast agent within the 6 months before the clinical worsening of hypothyroidism;
  25. (25)
    taking a drug from the specified list of drugs within the 6 months before the clinical worsening of hypothyroidism;

    Note: specified list of drugs is defined in the Schedule 1 - Dictionary.

  26. (26)
    taking minocycline for at least 6 months within the 9 months before the clinical worsening of hypothyroidism;
  27. (27)
    taking a drug containing at least 10 milligrams of iodine daily for a continuous period of at least 4 weeks within the 6 months before the clinical worsening of hypothyroidism;
  28. (28)
    taking amiodarone for a continuous period of at least 2 weeks within the 1 year before the clinical worsening of hypothyroidism;
  29. (29)
    taking a drug that increases the requirement of thyroid hormone replacement therapy at the time of the clinical worsening of hypothyroidism;

    Note: Examples of drugs that may increase the requirement for thyroid hormone replacement therapy include 5-fluorouracil, antiretroviral drugs, clofibrate, raloxifene and tamoxifen.

  30. (30)
    being pregnant or within the 12 months postpartum at the time of the clinical worsening of hypothyroidism;
  31. (31)
    having a form of thyroiditis from the specified list of forms of thyroiditis at the time of the clinical worsening of hypothyroidism;

    Note: specified list of forms of thyroiditis is defined in the Schedule 1 - Dictionary.

  32. (32)
    undergoing a course of therapeutic radiation for cancer, where the thyroid gland was in the field of radiation, before the clinical worsening of hypothyroidism;
  33. (33)
    having received iodine-131 (radioactive iodine) treatment before the clinical worsening of hypothyroidism;
  34. (34)
    having subtotal or total thyroidectomy, or neck surgery involving the thyroid gland, before the clinical worsening of hypothyroidism;
  35. (35)
    having a disease involving the thyroid gland from the specified list of diseases at the time of the clinical worsening of hypothyroidism;

    Note: specified list of diseases is defined in the Schedule 1 - Dictionary.

  36. (36)
    having a primary or secondary malignant neoplasm of the thyroid gland at the time of the clinical worsening of hypothyroidism;
  37. (37)
    having a type 3 deiodinase-overexpressing neoplasm before the clinical worsening of hypothyroidism;
  38. (38)
    having hypopituitarism involving deficiency of thyroid-stimulating hormone at the time of the clinical worsening of hypothyroidism;
  39. (39)
    having chronic kidney disease at the time of the clinical worsening of hypothyroidism;

    Note: chronic kidney disease is defined in the Schedule 1 - Dictionary.

  40. (40)
    having hepatitis C virus infection at the time of the clinical worsening of hypothyroidism;
  41. (41)
    being obese for at least 5 years before the clinical worsening of hypothyroidism;

    Note: being obese is defined in the Schedule 1 - Dictionary.

  42. (42)
    having posttraumatic stress disorder at the time of the clinical worsening of hypothyroidism;
  43. (43)
    for myxoedema coma only, having an acute precipitating event within the 48 hours before that clinical worsening of hypothyroidism;

    Note: acute precipitating event and myxoedema coma are defined in the Schedule 1 - Dictionary.

  44. (44)
    inability to obtain appropriate clinical management for hypothyroidism;

Aggravation-only factors: the factors in subsections 9(22) to 9(44) apply only to material contribution to, or aggravation of, the condition where it was suffered or contracted before or during (but did not arise out of) the person’s relevant service.

Balance of Probabilities (BoP) — Statement of Principles No. 4 of 2022

36 factors

At least one of the following factors must exist before it can be said that, on the balance of probabilities, hypothyroidism or death from hypothyroidism is connected with the circumstances of a person's relevant service:

  1. (1)
    having iodine deficiency within the 3 months before the clinical onset of hypothyroidism;

    Note: iodine deficiency is defined in the Schedule 1 - Dictionary.

  2. (2)
    having iodine excess within the 3 months before the clinical onset of hypothyroidism;

    Note: Iodine excess may be due to consuming foods, dietary supplements or medications with a high content of iodine.

    Note: iodine excess is defined in the Schedule 1 - Dictionary.

  3. (3)
    being administered an iodine-containing radiographic contrast agent within the 3 months before the clinical onset of hypothyroidism;
  4. (4)
    taking a drug from the specified list of drugs within the 3 months before the clinical onset of hypothyroidism;

    Note: specified list of drugs is defined in the Schedule 1 - Dictionary.

  5. (5)
    taking a drug containing at least 10 milligrams of iodine daily for a continuous period of at least 4 weeks within the 3 months before the clinical onset of hypothyroidism;
  6. (6)
    taking amiodarone for a continuous period of at least 2 weeks within the 1 year before the clinical onset of hypothyroidism;
  7. (7)
    being pregnant or within the 12 months postpartum at the time of the clinical onset of hypothyroidism;
  8. (8)
    having a form of thyroiditis from the specified list of forms of thyroiditis at the time of the clinical onset of hypothyroidism;

    Note: specified list of forms of thyroiditis is defined in the Schedule 1 - Dictionary.

  9. (9)
    undergoing a course of therapeutic radiation for cancer, where the thyroid gland was in the field of radiation, before the clinical onset of hypothyroidism;
  10. (10)
    having received iodine-131 (radioactive iodine) treatment before the clinical onset of hypothyroidism;
  11. (11)
    having subtotal or total thyroidectomy, or neck surgery involving the thyroid gland, before the clinical onset of hypothyroidism;
  12. (12)
    having a disease involving the thyroid gland from the specified list of diseases at the time of the clinical onset of hypothyroidism;

    Note: specified list of diseases is defined in the Schedule 1 - Dictionary.

  13. (13)
    having a primary or secondary malignant neoplasm of the thyroid gland at the time of the clinical onset of hypothyroidism;
  14. (14)
    having a type 3 deiodinase-overexpressing neoplasm before the clinical onset of hypothyroidism;
  15. (15)
    having hypopituitarism involving deficiency of thyroid-stimulating hormone at the time of the clinical onset of hypothyroidism;
  16. (16)
    being obese for at least 5 years before the clinical onset of hypothyroidism;

    Note: being obese is defined in the Schedule 1 - Dictionary.

  17. (17)
    for hypothyroidism first presenting as myxoedema coma only, having an acute precipitating event within the 48 hours before the clinical onset of hypothyroidism;

    Note: acute precipitating event and myxoedema coma are defined in the Schedule 1 - Dictionary.

  18. (18)
    having iodine deficiency within the 3 months before the clinical worsening of hypothyroidism;

    Note: iodine deficiency is defined in the Schedule 1 - Dictionary.

  19. (19)
    having iodine excess within the 3 months before the clinical worsening of hypothyroidism;

    Note: Iodine excess may be due to consuming foods, dietary supplements or medications with a high content of iodine.

    Note: iodine excess is defined in the Schedule 1 - Dictionary.

  20. (20)
    being administered an iodine-containing radiographic contrast agent within the 3 months before the clinical worsening of hypothyroidism;
  21. (21)
    taking a drug from the specified list of drugs within the 3 months before the clinical worsening of hypothyroidism;

    Note: specified list of drugs is defined in the Schedule 1 - Dictionary.

  22. (22)
    taking a drug containing at least 10 milligrams of iodine daily for a continuous period of at least 4 weeks within the 3 months before the clinical worsening of hypothyroidism;
  23. (23)
    taking amiodarone for a continuous period of at least 2 weeks within the 1 year before the clinical worsening of hypothyroidism;
  24. (24)
    taking a drug that increases the requirement of thyroid hormone replacement therapy at the time of the clinical worsening of hypothyroidism;

    Note: Examples of drugs that may increase the requirement for thyroid hormone replacement therapy include 5-fluorouracil, antiretroviral drugs, clofibrate, raloxifene and tamoxifen.

  25. (25)
    being pregnant or within the 12 months postpartum at the time of the clinical worsening of hypothyroidism;
  26. (26)
    having a form of thyroiditis from the specified list of forms of thyroiditis at the time of the clinical worsening of hypothyroidism;

    Note: specified list of forms of thyroiditis is defined in the Schedule 1 - Dictionary.

  27. (27)
    undergoing a course of therapeutic radiation for cancer, where the thyroid gland was in the field of radiation, before the clinical worsening of hypothyroidism;
  28. (28)
    having received iodine-131 (radioactive iodine) treatment before the clinical worsening of hypothyroidism;
  29. (29)
    having subtotal or total thyroidectomy, or neck surgery involving the thyroid gland, before the clinical worsening of hypothyroidism;
  30. (30)
    having a disease involving the thyroid gland from the specified list of diseases at the time of the clinical worsening of hypothyroidism;

    Note: specified list of diseases is defined in the Schedule 1 - Dictionary.

  31. (31)
    having a primary or secondary malignant neoplasm of the thyroid gland at the time of the clinical worsening of hypothyroidism;
  32. (32)
    having a type 3 deiodinase-overexpressing neoplasm before the clinical worsening of hypothyroidism;
  33. (33)
    having hypopituitarism involving deficiency of thyroid-stimulating hormone at the time of the clinical worsening of hypothyroidism;
  34. (34)
    being obese for at least 5 years before the clinical worsening of hypothyroidism;

    Note: being obese is defined in the Schedule 1 - Dictionary.

  35. (35)
    for myxoedema coma only, having an acute precipitating event within the 48 hours before that clinical worsening of hypothyroidism;

    Note: acute precipitating event and myxoedema coma are defined in the Schedule 1 - Dictionary.

  36. (36)
    inability to obtain appropriate clinical management for hypothyroidism;

Aggravation-only factors: the factors in subsections 9(18) to 9(36) apply only to material contribution to, or aggravation of, the condition where it was suffered or contracted before or during (but did not arise out of) the person’s relevant service.

A VHC Diagnostic Assessment addresses each of these factors one by one against your service record and clinical history. See how a VHC DVA claim works, see all fees ($600 + GST per stage) or book an appointment.

About Dr Thomas Perkins

One doctor. Every report.

Founding doctor of the Veterans Health Centre in Ipswich, Queensland, and one of Australia's most experienced practitioners in veterans' medicolegal medicine.

Dr Perkins has spent more than thirteen years working exclusively with current and former ADF members — treating their conditions, writing their reports and navigating the DVA system alongside them. With over 100,000 claims submitted and 2,000 Permanent Impairment Assessments completed, he has seen precisely what separates an accepted claim from a rejected one at every level, from initial liability to the Veterans' Review Board.

Every chart review, diagnostic assessment, impairment rating and appeal that leaves this clinic is personally overseen by Dr Perkins. No template, no locum, no hand-off.

0429 146 039 reception@vhc.org.au

Book appointment